Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Using a patient's own tooth material plus PRF or albumin-PRF to preserve the extraction socket

Official title: Comparison of Autogenous Dentin Graft With Albumin Platelet Rich Fibrin Versus Autogenous Dentin Graft With Platelet Rich Fibrin in Alveolar Socket Preservation: A Randomized Controlled Clinical Trial.

Run by Kafrelsheikh University · NCT06757218 · Data updated 2026-11-12

This test tries whether filling a lower back tooth extraction socket with the patient's own dentin plus either standard PRF or albumin-enhanced PRF better preserves jaw bone in healthy adults aged 18–60.

More Socket Preservation trials

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment60 (estimated)
SponsorKafrelsheikh University
Academic / other
Locations1 site (Kafr ash Shaykh, Kafrelsheikh)
StatusRecruiting
StartedJune 1, 2025
Main results expectedJune 30, 2026
Study endsAugust 30, 2026
Registry record updatedJuly 10, 2025
Trial IDNCT06757218 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults 18–60 with a non-restorable posterior mandibular tooth scheduled for extraction, without systemic disease, not pregnant or lactating, non-smokers, and with good oral hygiene are ideal candidates.

Probably not a fit

Patients with systemic illnesses, smokers, pregnant or lactating individuals, those with bone diseases or poor oral hygiene, or those needing anterior tooth treatment are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants are randomly assigned to one of three groups: empty socket (spontaneous healing), autogenous dentin graft with standard platelet-rich fibrin (PRF) block, or autogenous dentin graft with albumin-PRF (Alb-PRF) block, with 20 sockets per group. The removed tooth is cleaned, ground to 300–1200 μm particles, demineralized, rinsed, and dried to make the autogenous dentin graft, while PRF is prepared from a 10 ml blood draw and Alb-PRF is formed by combining L-PRF with albumin to create a stable membrane. Outcomes focus on post-extraction socket changes and bone preservation that affect future implant or prosthetic planning, especially within the early healing window when most ridge loss occurs. Procedures and follow-up visits are performed at the single site with standardized surgical and graft preparation protocols.

Why it matters

Potential benefit: If successful, this approach could reduce bone loss after extraction, making future implant placement easier and possibly avoiding additional grafting.

How similar studies have gone: Previous reports indicate autogenous dentin grafts and PRF can support socket healing, while albumin-enriched PRF is a newer technique with limited but encouraging early data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Medically free patients.
* Adult patients above 18 Years to 60 Years.
* Non-restorable tooth indicated for extraction.
* Posterior mandibular teeth.
* Inactive infection related to the tooth.
* Cooperative patients.

Exclusion Criteria:

* Presence of any systemic disease that could influence the outcome of the therapy.
* Presence of any risk factor (smoker, pregnant and lactating patients).
* Patients with bone diseases.
* Patients with poor oral hygiene.

Where it's running

  • Kaferelsheikh University
    Kafr ash Shaykh, Kafrelsheikh, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.